AEON Biopharma, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
AEON Biopharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2023 to Q1 2024.
  • AEON Biopharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $25K, unchanged year-over-year.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $25K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $21K Jul 22, 2023 Sep 30, 2023 10-Q 2023-11-13
Q1 2023 $25K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.